Work

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.3987.3987

Authors: Taiga Nishihori, Jose L Ochoa-Bayona, Rachid Baz, Kenneth H. Shain, Christine Simonelli, Chiaka Nwoga, Ryan Hillgruber, Daniel Sullivan, Claudio Anasetti, Melissa Alsina

Institution: Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588960832

FWCI:

Cites:

Cited by:

Related to: 10